MX2012002486A - Metodos para tratar infecciones ortomixovirales. - Google Patents
Metodos para tratar infecciones ortomixovirales.Info
- Publication number
- MX2012002486A MX2012002486A MX2012002486A MX2012002486A MX2012002486A MX 2012002486 A MX2012002486 A MX 2012002486A MX 2012002486 A MX2012002486 A MX 2012002486A MX 2012002486 A MX2012002486 A MX 2012002486A MX 2012002486 A MX2012002486 A MX 2012002486A
- Authority
- MX
- Mexico
- Prior art keywords
- substituted
- unsubstituted
- groups
- use according
- virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27225409P | 2009-09-04 | 2009-09-04 | |
| US28250810P | 2010-02-22 | 2010-02-22 | |
| US35393510P | 2010-06-11 | 2010-06-11 | |
| PCT/US2010/047488 WO2011028775A1 (en) | 2009-09-04 | 2010-09-01 | Methods of treating orthomyxoviral infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012002486A true MX2012002486A (es) | 2012-09-07 |
Family
ID=43649616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012002486A MX2012002486A (es) | 2009-09-04 | 2010-09-01 | Metodos para tratar infecciones ortomixovirales. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20110065752A1 (enExample) |
| EP (1) | EP2473482B1 (enExample) |
| JP (1) | JP5653438B2 (enExample) |
| KR (1) | KR101497194B1 (enExample) |
| CN (1) | CN102625796B (enExample) |
| BR (1) | BR112012004676A2 (enExample) |
| CA (1) | CA2772875A1 (enExample) |
| DK (1) | DK2473482T3 (enExample) |
| ES (1) | ES2466027T3 (enExample) |
| MX (1) | MX2012002486A (enExample) |
| PL (1) | PL2473482T3 (enExample) |
| WO (1) | WO2011028775A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2398321B1 (en) | 2009-02-23 | 2015-11-25 | United Therapeutics Corporation | Iminosugars and methods of treating viral diseases |
| WO2013184780A1 (en) | 2012-06-06 | 2013-12-12 | Unither Virology, Llc | Novel iminosugars and their applications |
| WO2015039010A2 (en) * | 2013-09-16 | 2015-03-19 | Unither Virology, Llc | Deoxynojirimycin derivatives and methods of their using |
| WO2016073652A1 (en) | 2014-11-05 | 2016-05-12 | Unither Virology, Llc | Iminosugars useful for the treatment of viral diseases |
| WO2017201030A1 (en) * | 2016-05-16 | 2017-11-23 | Emergent Virology Llc | Methods of treating viral infection |
| US20220257604A1 (en) * | 2019-03-08 | 2022-08-18 | University Of Virginia Patent Foundation | Compositions and methods for modulating viral infections by regulating glucosylceramides |
| CN111904959A (zh) * | 2020-08-21 | 2020-11-10 | 牡丹江医学院 | α-L-岩藻糖苷酶抑制剂在制备治疗小儿肺炎的药物中的用途 |
| IT202200007808A1 (it) * | 2022-04-20 | 2023-10-20 | Luigi Michele Pavone | Composizioni terapeutiche per malattie causate da accumulo di eparan solfato |
| CN119841765B (zh) * | 2025-01-09 | 2025-10-10 | 中南大学 | Dnj衍生物、药物组合物及其应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8013A (en) * | 1851-04-01 | Improvement in wheat-fans | ||
| GB1555654A (en) * | 1977-06-25 | 1979-11-14 | Exxon Research Engineering Co | Agricultural burner apparatus |
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
| DE2834122A1 (de) * | 1978-08-03 | 1980-02-14 | Bayer Ag | Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose |
| DE2839309A1 (de) * | 1978-09-09 | 1980-03-27 | Bayer Ag | 3,4,5-trihydroxypiperidin-derivate |
| DE2853573A1 (de) * | 1978-12-12 | 1980-07-03 | Bayer Ag | Herstellung von n-substituierten derivaten des l-desoxynojirimycins |
| DE3038901A1 (de) * | 1980-10-15 | 1982-05-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins |
| DE3611841A1 (de) * | 1986-04-09 | 1987-10-15 | Bayer Ag | Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten |
| US5043273A (en) * | 1989-08-17 | 1991-08-27 | Monsanto Company | Phosphorylated glycosidase inhibitor prodrugs |
| US5103008A (en) * | 1989-08-17 | 1992-04-07 | Monsanto Company | Compound, N-butyl-deoxynojirimycin-6-phosphate |
| US4994572A (en) * | 1989-10-12 | 1991-02-19 | Monsanto Company | Synthesis of nojirimycin derivatives |
| US5030638A (en) * | 1990-02-26 | 1991-07-09 | G. D. Searle & Co. | Method of antiviral enhancement |
| US5200523A (en) * | 1990-10-10 | 1993-04-06 | Monsanto Company | Synthesis of nojirimycin derivatives |
| US5206251A (en) * | 1992-04-01 | 1993-04-27 | G. D. Searle & Co. | 2- and 3- amino and azido derivatives of 1,5-iminosugars |
| US5399567A (en) * | 1993-05-13 | 1995-03-21 | Monsanto Company | Method of treating cholera |
| AU1876095A (en) * | 1994-02-25 | 1995-09-11 | G.D. Searle & Co. | Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
| US6465487B1 (en) * | 1997-12-11 | 2002-10-15 | Synergy Pharmaceuticals, Inc. | Inhibition of membrane-associated viral replication |
| US6689759B1 (en) * | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
| US6610703B1 (en) * | 1998-12-10 | 2003-08-26 | G.D. Searle & Co. | Method for treatment of glycolipid storage diseases |
| GB9828474D0 (en) * | 1998-12-24 | 1999-02-17 | British Aerospace | Surface topology inspection |
| EP1165080A2 (en) * | 1999-02-12 | 2002-01-02 | G.D. SEARLE & CO. | Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| GB0100889D0 (en) * | 2001-01-12 | 2001-02-21 | Oxford Glycosciences Uk Ltd | Compounds |
| AU6050600A (en) * | 1999-07-26 | 2001-02-13 | G.D. Searle & Co. | Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidaseenzyme for the manufacture of medicament for the treatment of glycolipid storag e diseases |
| US7256005B2 (en) * | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
| AU1840101A (en) * | 1999-08-10 | 2001-03-05 | Chancellor, Masters And Scholars Of The University Of Oxford, The | Long chain n-alkyl compounds and oxo-derivatives thereof |
| PT2444102E (pt) * | 2003-01-31 | 2015-09-17 | Sinai School Medicine | Terapia combinada para o tratamento de distúrbios de deficiência proteica |
| US7446098B2 (en) * | 2003-02-18 | 2008-11-04 | Mount Sinai School Of Medicine Of New York University | Combination therapy for treating protein deficiencies |
| US20050256168A1 (en) * | 2004-04-28 | 2005-11-17 | Block Timothy M | Compositions for oral administration for the treatment of interferon-responsive disorders |
| US7524829B2 (en) * | 2004-11-01 | 2009-04-28 | Avi Biopharma, Inc. | Antisense antiviral compounds and methods for treating a filovirus infection |
| GB0501352D0 (en) * | 2005-01-21 | 2005-03-02 | Slingsby Jason H | Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope |
| JP2008533175A (ja) * | 2005-03-16 | 2008-08-21 | ユニバーシティ・オブ・オックスフォード | Ｈｉｖ−１のためのマンノース免疫原 |
| EP2932982B1 (en) * | 2005-05-17 | 2018-10-03 | Amicus Therapeutics, Inc. | A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives |
| AU2006272586A1 (en) * | 2005-07-27 | 2007-02-01 | University Of Florida Research Foundation, Inc. | Use of heat shock to treat ocular disease |
| AU2006272497B2 (en) * | 2005-07-27 | 2012-07-19 | University Of Florida Research Foundation, Inc. | Small compounds that correct protein misfolding and uses thereof |
| US20070244184A1 (en) * | 2006-01-09 | 2007-10-18 | Simon Fraser University | Glycosidase inhibitors and methods of synthesizing same |
| CA2650311A1 (en) * | 2006-04-24 | 2007-11-01 | Academisch Medisch Centrum | Improved treatment of cystic fibrosis |
| EP2023927B1 (en) * | 2006-05-24 | 2015-02-25 | United Therapeutics Corporation | Deoxynojirimycin and d-arabinitol analogs and methods of using |
| EP2356990A3 (en) * | 2006-08-02 | 2011-10-19 | University of Oxford | Liposome treatment of viral infections |
| EP2054076A2 (en) * | 2006-08-21 | 2009-05-06 | United Therapeutics Corporation | Combination therapy for treatment of viral infections |
| CN101172127B (zh) * | 2006-10-31 | 2011-12-07 | 上海市新文达生物科技有限公司 | 一种桑叶提取物及其在制备抗甲型流感病毒药物中的应用 |
| WO2009118658A2 (en) * | 2008-03-26 | 2009-10-01 | University Of Oxford | Endoplasmic reticulum targeting liposomes |
| CN101278977B (zh) * | 2008-03-31 | 2012-05-30 | 广州唐百服生物科技有限公司 | 一种桑叶主要活性成分的提取方法及其提取物用途 |
-
2010
- 2010-09-01 CA CA2772875A patent/CA2772875A1/en not_active Abandoned
- 2010-09-01 MX MX2012002486A patent/MX2012002486A/es active IP Right Grant
- 2010-09-01 WO PCT/US2010/047488 patent/WO2011028775A1/en not_active Ceased
- 2010-09-01 US US12/873,704 patent/US20110065752A1/en not_active Abandoned
- 2010-09-01 EP EP10814409.8A patent/EP2473482B1/en not_active Not-in-force
- 2010-09-01 ES ES10814409.8T patent/ES2466027T3/es active Active
- 2010-09-01 PL PL10814409T patent/PL2473482T3/pl unknown
- 2010-09-01 DK DK10814409.8T patent/DK2473482T3/da active
- 2010-09-01 KR KR1020127007709A patent/KR101497194B1/ko not_active Expired - Fee Related
- 2010-09-01 JP JP2012528002A patent/JP5653438B2/ja not_active Expired - Fee Related
- 2010-09-01 CN CN201080048403.3A patent/CN102625796B/zh not_active Expired - Fee Related
- 2010-09-01 BR BR112012004676A patent/BR112012004676A2/pt not_active IP Right Cessation
-
2016
- 2016-05-04 US US15/145,981 patent/US20160243096A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013503880A (ja) | 2013-02-04 |
| PL2473482T3 (pl) | 2014-09-30 |
| KR20120080584A (ko) | 2012-07-17 |
| JP5653438B2 (ja) | 2015-01-14 |
| DK2473482T3 (en) | 2014-05-12 |
| ES2466027T3 (es) | 2014-06-09 |
| BR112012004676A2 (pt) | 2019-09-24 |
| US20110065752A1 (en) | 2011-03-17 |
| CN102625796A (zh) | 2012-08-01 |
| EP2473482A1 (en) | 2012-07-11 |
| WO2011028775A1 (en) | 2011-03-10 |
| KR101497194B1 (ko) | 2015-02-27 |
| EP2473482B1 (en) | 2014-03-05 |
| EP2473482A4 (en) | 2013-01-16 |
| CN102625796B (zh) | 2015-03-11 |
| CA2772875A1 (en) | 2011-03-10 |
| US20160243096A1 (en) | 2016-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012002486A (es) | Metodos para tratar infecciones ortomixovirales. | |
| US9943532B2 (en) | Iminosugars and methods of treating viral diseases | |
| JP5634510B2 (ja) | イミノ糖ならびにブニヤウイルスおよびトガウイルス疾患を治療する方法 | |
| CN102625801B (zh) | 治疗痘病毒感染的方法 | |
| EP2473046B1 (en) | Iminosugars for their use in the treatment of filoviral diseases | |
| JP5951996B2 (ja) | イミノ糖及びアレナウイルス感染症を治療する方法 | |
| Ramstedt et al. | Methods of treating orthomyxoviral infections | |
| HK1168103A (en) | Methods of treating orthomyxoviral infections | |
| HK1165675B (en) | Iminosugars and methods of treating arenaviral infections | |
| HK1172270A (en) | Iminosugars and methods of treating bunyaviral and togaviral diseases | |
| HK1173723B (en) | Methods of treatlng poxviral infections | |
| HK1165221B (en) | Iminosugars and methods of treating viral diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |